Published in AIDS Weekly, April 24th, 2006
Both tests were evaluated by the National AIDS/STD Control Programme of the Kenyan Ministry of Health and met their sensitivity and specificity requirements. The approval allows Chembio to begin selling its products in the country.
Kenya has a population of approximately 34 million of which an estimated 1.2 million are infected with HIV. Under the President's $15 billion Emergency Plan for AIDS Relief (PEPFAR), the U.S. government plans to provide Kenya with $208 million in 2006 to support Kenya's fight against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.